AbbVie Inc. AI Forecast for 2026-2030
AI price forecast for AbbVie Inc. for 2026-2030 based on technical analysis, on-chain metrics, and market sentiment analysis.
AbbVie Inc. (ABBV) is trading at $244.22, ranked #17 by market cap. Over the last 30 days it has moved +0.0%, giving it a neutral short-term outlook with a medium risk profile. Measured against its all-time high of $261.64 and current momentum, our model projects an average ABBV price of $357.52 by 2030.
Current Price
$244.22
ATH: $261.64 (93%)
Sentiment
Neutral
Momentum: -0%
Tech Signal
SELL
3/8 of 8 indicators
Risk Level
Medium
Volatility: 0.1% / day
AbbVie Inc. Price Forecast 2026
Pessimistic
$214.69
-12.1%
Average
$244.22
+0.0%
Optimistic
$299.59
+22.7%
Yearly Forecast
| Year | Min | Avg | Max | Growth Potential |
|---|---|---|---|---|
| 2026 | $214.69 | $244.22 | $299.59 | +0% |
| 2027 | $210.36 | $268.63 | $377.89 | +10% |
| 2028 | $253.99 | $295.49 | $437.70 | +21% |
| 2029 | $258.87 | $325.03 | $500.05 | +33% |
| 2030 | $263.76 | $357.52 | $523.28 | +46% |
| 2031 | $268.64 | $393.26 | $523.28 | +61% |
| 2032 | $287.78 | $453.68 | $764.73 | +86% |
| 2033 | $299.83 | $481.34 | $784.92 | +97% |
| 2034 | $309.51 | $503.71 | $784.92 | +106% |
| 2035 | $317.98 | $523.38 | $784.92 | +114% |
| 2040 | $352.12 | $603.79 | $784.92 | +147% |
| 2050 | $405.46 | $733.21 | $1,308.20 | +200% |
AI Forecast Factors
Volatility
1%
Momentum
-0%
ATH Potential
1.1x
Room to ATH
Market Rank
#17
Factor: 1.21x
Scarcity
1.00x
Supply factor
Liquidity
0%
Bullish Factors
- Growing adoption and expanding use cases continue to strengthen the long-term outlook for AbbVie Inc..
- Improving market structure and rising institutional participation add support for ABBV over the forecast horizon.
- At rank #17, AbbVie Inc. retains room to climb as capital rotates into quality assets.
- A constructive macro backdrop could accelerate the next leg higher for AbbVie Inc..
Bearish Factors
- Trading close to its all-time high, AbbVie Inc. may face profit-taking and technical resistance.
- A market rank of #17 implies lower liquidity and higher sensitivity to broad market swings.
- Thin trading volume relative to market cap can amplify price swings in both directions.
- Broader market corrections and shifting macro conditions could weigh on AbbVie Inc..
- Regulatory uncertainty across key jurisdictions remains a persistent risk for ABBV.
Frequently Asked Questions
Is AbbVie Inc. a good investment in 2026?
AbbVie Inc. currently shows a neutral outlook with a medium risk profile. Our model projects an average price near $244.22 in 2026, though ABBV remains volatile — always do your own research.
What is the AbbVie Inc. price prediction for 2030?
For 2030 our AI model forecasts ABBV between $263.76 and $523.28, with an average target of $357.52.
How high can AbbVie Inc. realistically go?
In the most optimistic long-term scenario, AbbVie Inc. could reach around $1,308.20. This assumes strong adoption and favorable market conditions.
Why is the AbbVie Inc. forecast neutral?
This read is driven by current momentum of -0%, the distance to its all-time high, and a market position at rank #17.
Disclaimer
All forecasts and analytical data on Web3Forecast are provided for informational purposes only and do not constitute financial advice. Cryptocurrency investments carry high risk. Always do your own research before making investment decisions.